Logo 1 Logo 2

Clinical Trial Details

Trial ID: L5192
Source ID: NCT00097279
Associated Drug: Biphasic Insulin Aspart
Title: Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes
Acronym: ACTION
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes|Diabetes Mellitus, Type 2
Interventions: DRUG: biphasic insulin aspart|DRUG: pioglitazone|DRUG: metformin
Outcome Measures: Primary: HbA1c, After 24 weeks | Secondary: Safety variables|Other glycemic variables|8-point plasma glucose profiles
Sponsor/Collaborators: Sponsor: Novo Nordisk A/S
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 230
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2004-08
Completion Date: 2005-08
Results First Posted:
Last Update Posted: 2017-01-11
Locations: Novo Nordisk Investigational Site, Birmingham, Alabama, 35235, United States|Novo Nordisk Investigational Site, Glendale, Arizona, 85306, United States|Novo Nordisk Investigational Site, Phoenix, Arizona, 85006, United States|Novo Nordisk Investigational Site, Searcy, Arkansas, 72143, United States|Novo Nordisk Investigational Site, Burlingame, California, 94010, United States|Novo Nordisk Investigational Site, Chula Vista, California, 91911, United States|Novo Nordisk Investigational Site, Fullerton, California, 92835, United States|Novo Nordisk Investigational Site, Los Angeles, California, 90057, United States|Novo Nordisk Investigational Site, Redwood City, California, 94062, United States|Novo Nordisk Investigational Site, Denver, Colorado, 80262, United States|Novo Nordisk Investigational Site, New Britain, Connecticut, 06050, United States|Novo Nordisk Investigational Site, Newark, Delaware, 19713, United States|Novo Nordisk Investigational Site, Aventura, Florida, 33180, United States|Novo Nordisk Investigational Site, Fort Myers, Florida, 33907, United States|Novo Nordisk Investigational Site, Hollywood, Florida, 33021, United States|Novo Nordisk Investigational Site, Lake Mary, Florida, 32746, United States|Novo Nordisk Investigational Site, Melbourne, Florida, 32901, United States|Novo Nordisk Investigational Site, Ocala, Florida, 34471, United States|Novo Nordisk Investigational Site, Pembroke Pines, Florida, 33024, United States|Novo Nordisk Investigational Site, Tallahassee, Florida, 32308, United States|Novo Nordisk Investigational Site, West Palm Beach, Florida, 33401, United States|Novo Nordisk Investigational Site, Atlanta, Georgia, 30339, United States|Novo Nordisk Investigational Site, Columbus, Georgia, 31904, United States|Novo Nordisk Investigational Site, Savannah, Georgia, 31406, United States|Novo Nordisk Investigational Site, Boise, Idaho, 83702, United States|Novo Nordisk Investigational Site, Chicago, Illinois, 60607, United States|Novo Nordisk Investigational Site, Topeka, Kansas, 66606, United States|Novo Nordisk Investigational Site, Wichita, Kansas, 67205, United States|Novo Nordisk Investigational Site, Baton Rouge, Louisiana, 70808, United States|Novo Nordisk Investigational Site, Easton, Maryland, 21601, United States|Novo Nordisk Investigational Site, Danvers, Massachusetts, 01923, United States|Novo Nordisk Investigational Site, Salisbury, Massachusetts, 01952, United States|Novo Nordisk Investigational Site, Waltham, Massachusetts, 02453, United States|Novo Nordisk Investigational Site, Detroit, Michigan, 48235, United States|Novo Nordisk Investigational Site, Grand Rapids, Michigan, 49506, United States|Novo Nordisk Investigational Site, Livonia, Michigan, 48152, United States|Novo Nordisk Investigational Site, St. Cloud, Minnesota, 56303, United States|Novo Nordisk Investigational Site, Columbia, Missouri, 65212, United States|Novo Nordisk Investigational Site, Las Vegas, Nevada, 89030, United States|Novo Nordisk Investigational Site, Reno, Nevada, 89502-0111, United States|Novo Nordisk Investigational Site, Hampton, New Hampshire, 03842, United States|Novo Nordisk Investigational Site, Berlin, New Jersey, 08009, United States|Novo Nordisk Investigational Site, Turnersville, New Jersey, 08012, United States|Novo Nordisk Investigational Site, East Syracuse, New York, 13057, United States|Novo Nordisk Investigational Site, New York, New York, 10003, United States|Novo Nordisk Investigational Site, New York, New York, 10023, United States|Novo Nordisk Investigational Site, Greenville, North Carolina, 27834, United States|Novo Nordisk Investigational Site, Columbus, Ohio, 43203, United States|Novo Nordisk Investigational Site, Dayton, Ohio, 45406, United States|Novo Nordisk Investigational Site, Kettering, Ohio, 45429, United States|Novo Nordisk Investigational Site, Medford, Oregon, 97501, United States|Novo Nordisk Investigational Site, Melrose Park, Pennsylvania, 19027, United States|Novo Nordisk Investigational Site, Philadelphia, Pennsylvania, 19107, United States|Novo Nordisk Investigational Site, Greer, South Carolina, 29651, United States|Novo Nordisk Investigational Site, Chattanooga, Tennessee, 37404, United States|Novo Nordisk Investigational Site, Arlington, Texas, 76014, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75231, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75235, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75390-8858, United States|Novo Nordisk Investigational Site, Irving, Texas, 75061, United States|Novo Nordisk Investigational Site, Midland, Texas, 79707, United States|Novo Nordisk Investigational Site, San Antonio, Texas, 78229, United States|Novo Nordisk Investigational Site, Ogden, Utah, 84403, United States|Novo Nordisk Investigational Site, Newport News, Virginia, 23606, United States|Novo Nordisk Investigational Site, Norfolk, Virginia, 23507, United States|Novo Nordisk Investigational Site, Richmond, Virginia, 23249, United States|Novo Nordisk Investigational Site, Suffolk, Virginia, 23434, United States|Novo Nordisk Investigational Site, Warrenton, Virginia, 20186, United States|Novo Nordisk Investigational Site, Kirkland, Washington, 98034, United States|Novo Nordisk Investigational Site, Olympia, Washington, 98502, United States|Novo Nordisk Investigational Site, Renton, Washington, 98057, United States|Novo Nordisk Investigational Site, Tacoma, Washington, 98405, United States|Novo Nordisk Investigational Site, Milwaukee, Wisconsin, 53209, United States
URL: https://clinicaltrials.gov/show/NCT00097279

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress
D336 Pioglitazone small molecule DB01132 Details
D089 Metformin small molecule DB00331 Details